LifeLink Ventures logo

LifeLink Ventures

Europe, Catalonia, Spain, Barcelona

Description

Life sciences focused investment firm

Investor Profile

LifeLink Ventures has made 4 investments, with 1 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (75%)
  • Seed (25%)

Country Focus

  • United Kingdom (50%)
  • United States (50%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Biopharma
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does LifeLink Ventures frequently co-invest with?

BACKED VC
Europe, England, United Kingdom, London
Co-Investments: 1
FAST — by GETTYLAB
North America, California, United States, San Francisco
Co-Investments: 1
H
Asia, T'ai-wan, Taiwan, Hsinchu
Co-Investments: 1
TGM ventures
North America, California, United States, Santa Monica
Co-Investments: 1
EIT Health
Europe, Bayern, Germany, Munich
Co-Investments: 1
Lifeforce Capital
North America, California, United States, San Francisco
Co-Investments: 1
A
Europe, Dublin, Ireland, Dublin
Co-Investments: 1
Bioverge
North America, California, United States, San Francisco
Co-Investments: 1
Acequia Capital (AceCap)
North America, Washington, United States, Seattle
Co-Investments: 1
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 1

Which angels does LifeLink Ventures often collaborate with?

AZ
North America, California, United States, San Francisco
Shared Deals: 1
MA
North America, California, United States, San Francisco
Shared Deals: 1
KF
North America, California, United States, San Francisco
Shared Deals: 1
MC
North America, New York, United States, New York
Shared Deals: 1

What are some of recent deals done by LifeLink Ventures?

Arda Therapeutics

San Francisco, California, United States

Arda is taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions.

BiotechnologyHealth CareTherapeutics
Series AOct 1, 2024
Amount Raised: $43,000,000
Ochre Bio

Oxford, Oxfordshire, United Kingdom

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

BiopharmaBiotechnologyHealth CareTherapeutics
Series AOct 10, 2022
Amount Raised: $30,000,000
Ochre Bio

Oxford, Oxfordshire, United Kingdom

Ochre Bio is a biotechnology company that develops and builds a deep phenotyping platform to rejuvenate transplant livers.

BiopharmaBiotechnologyHealth CareTherapeutics
Series ADec 10, 2021
Chameleon Biosciences

San Anselmo, California, United States

Chameleon Biosciences is transforming gene therapy with a re-dosable, AAV based gene therapy.

BiotechnologyGeneticsTherapeutics
SeedMar 25, 2021
Amount Raised: $11,100,000